✦ LIBER ✦

419 - Combined therapy of amifostine and gemcltabine in high-risk myelodysplastic syndromes

✍ Scribed by O. Sezer; G. Oingeldein; H.-G. Mergenthaler; K. Possinger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

163 Amifostine in low-risk and combined

✍ O. Sezer; M. Stefanic; G. Dingeldein; H.-G. Mergenthaler; K. Possinger 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Amifostine alone and in combination with

✍ Ayalew Tefferi; Michelle A. Elliott; David P. Steensma; C.Christopher Hook; Ange 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The challenge of individualised risk ass

✍ Reinhard Stauder 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

Intensive therapy for high-risk myelodys

✍ W Hiddemann; G Jahns-Streubel; W Verbeek; B Wörmann; D Haase; C Schoch 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Arsenic trioxide, thalidomide and retino

✍ Wen-Li Zheng; Guang-Sen Zhang; Yun-Xiao Xu; Jian-Kai Shen; Chong-Wen Dai; Min-Fe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Limitations of targeted therapy with sor

✍ Wei, Andrew; Tan, Peter 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 143 KB